Ambroxol

Ambroxol
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	oral, inhaled, intramuscular, intravenous
ATC code	R05CB06 (WHO) R02AD05 (WHO);
Legal status
Legal status	In general: Over-the-counter (OTC);
Identifiers
	IUPAC name trans-4-(2-Amino-3,5-dibromobenzylamino)-cyclohexanol;
CAS Number	18683-91-5 ;
PubChem CID	2132;
ChemSpider	10276826 ;
UNII	200168S0CL;
KEGG	D07442 ;
ChEMBL	ChEMBL153479 ;
CompTox Dashboard (EPA)	DTXSID8022583 ;
ECHA InfoCard	100.038.621
Chemical and physical data
Formula	C13H18Br2N2O
Molar mass	378.108 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@H]2CC[C@H](NCc1cc(Br)cc(Br)c1N)CC2;
	InChI InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2/t10-,11- ; Key:JBDGDEWWOUBZPM-XYPYZODXSA-N ;
	(what is this?) (verify)

Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup.

It was patented in 1966 and came into medical use in 1979.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.